Correlation of cytokine levels and response to radiation therapy and/or brachytherapy in low/intermediate risk prostate cancer.

被引：0
|
作者：
Ashamalla, H
Marella, V
Feliberti, J
Kavosh, E
Guirguis, A
Fahim, O
Wise, G
机构：
[1] NY Methodist Hosp, Brooklyn, NY USA
[2] Maimonides Hosp, Brooklyn, NY 11219 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：190S / 190S
页数：1
相关论文
共 50 条
  • [31] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [32] Radiation therapy for intermediate risk prostate cancer: Dose escalation or hormonal therapy?
    Hannoun-Levi, J.
    Salem, N.
    Azria, D.
    Chamorey, E.
    Ginot, A.
    Moro, M.
    Cowen, D.
    Teissier, E.
    Ellis, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S379 - S379
  • [33] Correlation of post-treatment prostate biopsy radiation effect with biochemical response following high dose rate brachytherapy boost for prostate cancer.
    Goldstein, NS
    Martinez, AA
    Vicini, FA
    Stromberg, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 83A - 83A
  • [34] PREDICTORS OF PROSTATE CANCER SPECIFIC MORTALITY IN ELDERLY MEN WITH INTERMEDIATE-RISK PROSTATE CANCER TREATED WITH BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION THERAPY
    Nanda, Akash
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Dosoretz, Daniel
    Salenius, Sharon
    Katin, Michael
    Ross, Rudi
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 147 - 152
  • [35] Stereotactic body radiation therapy for low- and low-intermediate-risk prostate cancer: is there a dose effect?
    Katz, Alan J.
    Santoro, Michael
    Ashley, Richard
    Diblasio, Ferdinand
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [36] Radiation therapy and irreversible electroporation for intermediate risk prostate cancer (RTIRE).
    McClure, Timothy D.
    Ballman, Karla V.
    Marciscano, Ariel E. E.
    Barbieri, Christopher
    Nagar, Himanshu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [37] Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
    Diven, Marshall
    Ballman, Karla
    Marciscano, Ariel
    Barbieri, Christopher
    Piscopo, Jennifer
    Wang, Shu
    Nagar, Himanshu
    Mcclure, Timothy
    BMC UROLOGY, 2024, 24 (01):
  • [38] Radiation Therapy and Irreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)
    Diven, M.
    McClure, T. D.
    Ballman, K.
    Marciscano, A. E.
    Barbieri, C. E.
    Nagar, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E377 - E378
  • [39] Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer
    Graff, P.
    Malavaud, B.
    Portalez, D.
    Brun, T.
    Aziza, R.
    Lusque, A.
    Filleron, T.
    Bachaud, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E235 - E236
  • [40] The use of finasteride in reduction of prostate volume prior to brachytherapy treatment in low and intermediate risk prostate cancer
    Foran, A.
    Foran, P.
    McNicholas, M.
    Maher, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S138 - S138
12345